A clinical-radiomics integrated nomogram for predicting 5-year survival in rheumatoid arthritis-associated interstitial lung disease

Key Points

• This research aims to develop a user-friendly nomogram for predicting 5-year survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
• Developed an integrated nomogram incorporating age, lymphocyte count, and Rad-score.
• Utilized clinical and radiomic data to assess survival predictions.
• Analyzed the effectiveness of the nomogram against current guidelines.
• The nomogram successfully predicts 5-year survival with high precision.
• It addresses specific clinical needs overlooked by existing guidelines.
• Supports personalized management of RA-ILD patients.